力大圖書
力 大 醫 學 圖 書 網          www.leaderbook.com.tw          歡迎使用  國民旅遊卡!!
帳號 密碼
加入會員 | 首頁 | 服務 | 討論 | 留言 | 行銷回應 | 代訂 | 購物車 | 預訂清單
  
Search
      圖書搜尋

 - 進階搜尋
  代訂書籍
  加購書籍專區
Classes
      圖書類別
國民旅遊卡使用須知
購買注意事項
力大中文圖書
橘井文化系列叢書
免疫風濕科
內分泌科
內科(家醫科及實証醫學)
婦產科
眼科
病理科(檢驗科)
外科
耳鼻喉科(聽力和語言治療)
泌尿科
胸腔內科(重症醫學)
胸腔外科
腫瘤科(血液科)
放射腫瘤科
麻醉科(疼痛科)
獸醫科
神經外科
神經內科
小兒科
心臟內科
心臟外科
急診科
感染科
放射線科
核子醫科
牙科(口腔外科)
皮膚科(醫學美容)
精神科
胃腸科
骨科
腎臟科
整形外科
藥劑科
復健科(運動醫學)
護理科
限量特價專區
SPRINGER庫存出清專區
解剖學(組織學)
基礎醫學科
醫學系列書籍
醫學模型
醫學掛圖
 
 
 
-■ ■ ■ ■ ■ ■ 圖 書 介 紹
Immunomodulating Drugs for the Treatment of Cancer Hardbound + Online
-腫瘤科(血液科)
- 編號: 0-000000000000016054733329
- 作者:Asher A Chanan-
- 原價-4500    - (熱賣價)3600     - 節省 ↓20%
- 加入購物車
推薦指數:
- 內容介紹
Immunomodulating Drugs for the Treatment of Cancer Hardbound

Author(s):
Asher A Chanan-Khan MD

ISBN-10: 1-60547-333-2
ISBN-13: 978-1-60547-333-8
Pub Date: April 2011
Pages: 400
Illustrations: 208
Trim Size: 8.375 x 10.875
--Focuses on the scientific/preclinical information published that led to the development of these compounds in cancer medicine
--Outlines in detail the various clinical trials and current clinical application of these agents in various cancers
--Addresses the unique toxicity profile that is typically associated with these compounds
--Touches on the ongoing investigation and future direction of these drugs
Immunomodulatory (IMiDs) drugs are a new class of anticancer agents that has made a tremendous impact on the treatment of patients with various malignant diseases, including blood cancers and several cancers of the solid organs. Their popularity in prescribing is based on several important characteristics including: (1) oral bioavailability, (2) non-chemotherapeutic, (3) extremely well-tolerated in all age groups, (4) ability to activate patient's own immune response against cancer, (5) ease of combination with other agents such as chemotherapy resulting in higher responses as well as (6) variability of anticancer activity and a number of cancers. While there is a lot of literature published on these agents, there is no textbook that provides a comprehensive resource for clinicians and researchers regarding these agents and their rapidly emerging role in cancer medicine.

The clinical applications of these agents are not limited to oncologists and hematologists, but also impact primary care doctors who care for these patients. Furthermore, new investigations are defining the role of these agents in non-malignant disorders as well. Immunomodulating Drugs for the Treatment of Cancer brings the most current information on these novel compounds to clinicians and scientists involved in the care of cancer patients.

A companion website offers the fully searchable text and an image bank.
Table Of Contents
Part 1: INTRODUCTION

1: Introduction

Part 2: PRECLINICAL DEVELOPMENT

2: Antiangiogenic Activity of Immunomodulating Agents

3: Immunomodulating Effects of IMiD Molecules

4: Preclinical Investigations of IMiDs in B-Cell Malignancies

Part 3: CLINICAL DEVELOPMENT

5: Overview: Clinical Impact of IMiDs in Oncology

6: Thalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

7: IMiDs in Previously Untreated Multiple Myeloma

8: Thalidomide for Monoclonal Gammopathy of Unknown Significance (MGUS)

9: IMiDs for the Treatment of Elderly Myeloma Patients

10: IMiDs as Maintenance Therapy in Multiple Myeloma

11: Lenalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma

12: IMiDs and Stem Cell Transplantation in Multiple Myeloma

13: IMiDs in Waldenstrom's Macroglobulinemia

14: Lenalidomide for the Treatment of Myelodysplastic Syndrome

15: Lenalidomide for the Treatment of Myelofibrosis

16: IMiDs in Chronic Lymphocytic Leukemia

17: Novel Combinations of Lenalidomide in Multiple Myeloma

18: Lenalidomide Therapy in Non-Hodgkin's Lymphoma

19: Clinical Efficacy of IMiDs in Amyloidosis

20: Role of IMiDs in Malignant Melanoma

21: IMiDs for the Treatment of Prostate Cancer

22: IMiDs in Lung Cancer

23: IMiDs in Renal Cell Cancer

Part 4: COMPLICATIONS

24: IMiDs Associated Toxicity in Multiple Myeloma

25: IMiDs Associated Toxicity in MDS

26: IMiDs Associated Toxicity in Chronic Lymphocytic Leukemia

27: Management of Thrombotic Complications of IMiDs





歡迎使用國民旅遊卡
歡迎使用國民旅遊卡
其他相關書藉
  請輸入關鍵字
相 關 書 藉
The Desktop Guide to Complementary and Alternative Medicine
- 腫瘤科(血液科)
- 作者:Professor Edzard Ernst
A Beginner's Guide to Targeted Cancer Treatments 2018
- 腫瘤科(血液科)
- 作者:Elaine Vickers
Clinical Hematology Atlas 4/E(已絕版)
- 腫瘤科(血液科)
- 作者:Carr J.H., Rodak B.F
Companion Handbook to The Chemotherapy Sourcebook Softbound 2/E
- 腫瘤科(血液科)
- 作者:Michael C Perry MD, FACP
The Modern Technology of Radiation Oncology:
- 腫瘤科(血液科)
- 作者:J. Van Dyk
--- more
[ 積點系統 ]
您已經累積多少點數您知道嗎?別忘了登錄會員,察看您的點數,獎品就等您來拿喲!
[ 訂購辦法 ]
您還不知道要在本網站如何購物嗎?我們將會提供給您訂購的方法及購物相關資訊喲!讓您彈指間取得想要的書藉。
 
      圖書搜尋         本網站購物機制使用 SSL+ 加密技術,請放心購物 Safe100%

| 加入會員 | 回首頁 | 服務中心 | 行銷回應 | 購物須知 | 會員條款 | 關於力大 | 權益申明 | 合作對象 |

本站內容為 力大圖書有限公司 所有,未經同意,請勿任意引用轉載
電話:(02)2733-2592 傳真:(02)2732-5743 E-mail:service@leaderbook.com.tw
力大圖書:台北市和平東路二段90巷2號4樓之2  台中分店:臺中榮總婦幼大樓1F
Copyright 2002-2010 LeaderBook CO.,LTD All rights reserved.